| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 2026-02-18 | 16,644 | $5.82 | $96.92kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-18 | 4,134 | $5.82 | $24.07kSell |
| Ilan Ganot | Director | 2026-02-18 | 2,658 | $5.82 | $15.48kSell |
| David T. Howton | Chief Operating Officer | 2026-02-18 | 7,469 | $5.82 | $43.49kSell |
| Paul Herzich | Chief Technology Officer | 2026-02-18 | 3,616 | $5.82 | $21.06kSell |
| Kevin Tan | CFO Treasurer | 2026-02-18 | 5,404 | $5.82 | $31.47kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-04 | 12,348 | $6.44 | $79.55kSell |
| Gabriel Brooks | Chief Medical Officer | 2026-02-04 | 12,616 | $6.44 | $81.27kSell |
| Alexander Cumbo | President and CEO | 2026-02-04 | 48,913 | $6.44 | $315.10kSell |
| Ilan Ganot | Director | 2026-02-04 | 7,205 | $6.44 | $46.41kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 12.39% | 13,281,046 | $117.80M | Insider |
| Ra Capital Management LP | 10.83% | 11,608,856 | $102.97M | Insider |
| Ultragenyx Pharmaceutical Inc | 7.30% | 7,825,797 | $69.41M | Insider |
| Gilad David Hayeem | 4.79% | 5,136,501 | $45.56M | Insider |
| Bain Capital Life Sciences Investors LLC | 4.70% | 5,034,582 | $44.66M | Insider |
| Adam Koppel | 3.76% | 4,034,582 | $35.79M | Insider |
| Adage Capital Management LP | 3.73% | 3,995,539 | $35.44M | Insider |
| Matthew Bennett Arnold | 3.67% | 3,933,429 | $34.89M | Insider |
| Boxer Capital LLC | 3.24% | 3,473,272 | $30.81M | Insider |
| Chase Co Jpmorgan | 2.83% | 3,031,601 | $26.89M | Insider |